Point-of-care lateral flow diagnostic under development with BARDA funding for rapid detection of Burkholderia pseudomallei. Designed to enable detection of melioidosis in field and clinical settings.
Manufactured by
United States
Since 1996, InBios has been a leader in the development of diagnostic tests for emerging infectious diseases and biothreats. Products are designed for superior performance, efficiency and value. These include many FDA market authorized and CE marked assays for arboviruses, parasitic infections, biothreats, and more. InBios continues to anticipate and serve the growing global public health demand. Products in the pipeline include next generation platforms for tick-borne and respiratory diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
Verge HealthTech Fund
Singapore · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
Human Gesellschaft fuer Biochemica und Diagnostica mbH
Germany · 2 relevant products
Bio-Novum Sp.z o.o.
Poland · 1 relevant product
Micropore Filtration Solutions Pvt Ltd
India · 1 relevant product
Avecon Healthcare Pvt Ltd
India · 1 relevant product
Hangzhou Bigfish Bio-tech Co., Ltd.
China · 2 relevant products
Genesystem Co., Ltd.
South Korea · 1 relevant product
Helmut Hund GmbH
Germany · 2 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 80 closest product alternatives
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Point-of-care test for detection of malaria parasites using blood specimens. Designed for rapid diagnosis in endemic regions and clinical facilities.
Verge HealthTech Fund · Singapore
Laser-based diagnostic platform designed for rapid, multiplexed lateral flow testing with significantly reduced manufacturing costs. The technology provides sensitive and scalable point-of-care diagnostic capabilities for various clinical applications.
BioTeke Corporation(wuxi) Co.,Ltd · China
Lateral flow chromatographic technology-based immunoassay for rapid pathogen detection. Enables point-of-care diagnostic testing without specialized laboratory equipment.
Human Gesellschaft fuer Biochemica und Diagnostica mbH · Germany
Molecular diagnostic test for malaria detection using LAMP (loop-mediated isothermal amplification) technology. This test provides rapid identification of malaria parasites in clinical samples.
Bio-Novum Sp.z o.o. · Poland
Rapid diagnostic testing solution for point-of-care use in clinical settings. Enables quick identification of infections and diseases directly at the patient location.
Micropore Filtration Solutions Pvt Ltd · India
Lateral flow test membranes for rapid diagnostic applications and immunoassay development. Supports point-of-care testing and rapid detection formats in diagnostic platforms.
Human Gesellschaft fuer Biochemica und Diagnostica mbH · Germany
Molecular diagnostic test for tuberculosis detection using LAMP amplification technology. This rapid test is designed for identification of Mycobacterium tuberculosis in clinical specimens.
Avecon Healthcare Pvt Ltd · India
A lateral flow immunochromatography-based rapid test for malaria detection. Enables quick diagnosis in clinical laboratories and healthcare institutions with reliable performance.
Hangzhou Bigfish Bio-tech Co., Ltd. · China
Point-of-care testing kit for rapid molecular diagnosis with quick turnaround time. Designed for detection of specific pathogens or biomarkers in clinical samples.
Genesystem Co., Ltd. · South Korea
Rapid PCR-based test for detection of Mycobacterium tuberculosis using Genesystem biochip technology. Enables point-of-care diagnosis of tuberculosis infection.
Helmut Hund GmbH · Germany
Stand-alone device for quantitative analysis of lateral flow tests at point-of-care locations. Provides automated interpretation and reporting of rapid diagnostic test results without laboratory infrastructure.
E-proteins SCRL · Belgium
A complete system for rapid and sensitive detection in point-of-care diagnostics utilizing e-Proteins' avidin derivatives. Designed for quick turnaround results in clinical and field settings.
68 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products